Sanofi cuts $2.2B research deal with Covance

Intent on finding a new and more effective way of developing drugs, Sanofi-Aventis has struck a deal to sell two of its R&D sites in Europe to Covance while agreeing to pay the CRO up to $2.2 billion over 10 years to handle an important part of its research work. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.